Outlook Therapeutics (41O.F) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.85
-0.67
-0.48
-0.3

Details

Expected EPS
-0.3025719
Actual EPS
-0.3776784
Surprise EPS
-0.08
Surprise Percent
+24.82%

Description

Outlook Therapeutics (41O.F) has reported earnings of -0.3776784 per share for Q3 2025.

0 Comments

Share your thoughts